| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192367 | Annals of Allergy, Asthma & Immunology | 2010 | 9 Pages |
Abstract
Omalizumab reduced IgE-stimulated synthesis and secretion of proinflammatory cytokines by human ASMCs. These findings imply a beneficial action of omalizumab in asthma therapy. This effect is not restricted to inflammatory cells; it also includes tissue-forming cells.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Michael PhD, Michael MD,